Drug
VC005 clinical trials
Also written VC005.
- studies test it
- 19
- open now
- 8
- in phase 3
- 3
- first study started
- 2021
Keep track of what changes. Save the VC005 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
19 studies that test it; most in 2026 (8)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 7
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 19 · Other 0
Studies
Open first, then newest update. How each study uses VC005 is read from its arms, and is right about nine times in ten.
Testing it · 19
- A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataRecruitingPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07762443Written as VC005 tablets
- A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental VitiligoNot yet recruitingPhase 1/2Jiangsu vcare pharmaceutical technology co., LTDNCT07828639Written as VC005 tablets
- Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia AreataRecruitingPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT07749716Written as VC005 tablets
- Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisRecruitingPhase 3Jiangsu vcare pharmaceutical technology co., LTDNCT06723080Written as VC005 low dose group
- Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic DermatitisRecruitingPhase 3Jiangsu vcare pharmaceutical technology co., LTDNCT07592585Written as VC005
- A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic DermatitisRecruitingPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT07598383Written as VC005 group
- Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.RecruitingPhase 3Jiangsu vcare pharmaceutical technology co., LTDNCT07172360Written as VC005 tablets
- Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental VitiligoRecruitingPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT07172347Written as VC005 tablets
- Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07551557Written as VC005 Tablets
- Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal FunctionCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07551570Written as VC005 Tablets
- A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.CompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07533851Written as VC005 Tablets
- Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic DermatitisCompletedPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT06891040Written as VC005 groups
- Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic DermatitisCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07329101Written as VC005
- Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic DermatitisCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT06009094Written as VC005
- Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisCompletedPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT05997927Written as VC005 tablets
- Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.CompletedPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT05814939Written as VC005 tablets
- A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.CompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05874622Written as VC005 tablets
- Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy SubjectsCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05354752Written as VC005 tablets
- Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy SubjectsCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05138770Written as VC005 Tablets